Literature DB >> 8878073

Analysis of the action of idazoxan calls into question the reliability of the rat isolated small mesenteric artery assay as a predictor for alpha 1-adrenoceptor-mediated pressor activity.

P H Van der Graaf1, N P Shankley, J W Black.   

Abstract

We have studied the effects of idazoxan in rat aorta and small mesenteric artery. In the aorta, idazoxan behaved as a partial agonist (pKA = 6.30). Prazosin produced rightward shift (pA2 = 9.88) and steepening of the idazoxan curve. In contrast, idazoxan had no effect of basal tension in the mesenteric artery, but shifted the noradrenaline curve to the right in a parallel manner (pA2 = 6.12). The selective alpha 1-adrenoceptor agonist, indanidine, also behaved as a partial agonist in the aorta and produced no significant contractions of the small mesenteric artery. Since idazoxan and indanidine have been reported to raise blood pressure in the pithed rat via an action at vascular alpha 1-adrenoceptors, these results call into question the reliability of the small mesenteric artery assay as a predictor for alpha 1-adrenoceptor-mediated pressor activity in vivo.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8878073     DOI: 10.1007/bf00171074

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  9 in total

Review 1.  Structure and function of small arteries.

Authors:  M J Mulvany; C Aalkjaer
Journal:  Physiol Rev       Date:  1990-10       Impact factor: 37.312

2.  Effects of noradrenaline and neuropeptide Y on rat mesenteric microvessel contraction.

Authors:  H Chen; C Fetscher; R F Schäfers; G Wambach; T Philipp; M C Michel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-02       Impact factor: 3.000

3.  alpha 1-Adrenoceptor agonist activity of alpha 2-adrenoceptor antagonists in the pithed rat preparation.

Authors:  P M Paciorek; N B Shepperson
Journal:  Br J Pharmacol       Date:  1983-05       Impact factor: 8.739

4.  Sgd 101/75: cardiovascular effects in various animal preparations; interactions with vascular postjunctional alpha 1- and alpha 2-adrenoceptors.

Authors:  M J Mathy; M J Thoolen; P B Timmermans; P A van Zwieten
Journal:  Br J Pharmacol       Date:  1984-02       Impact factor: 8.739

5.  A study of the selectivity and potency of rauwolscine, RX 781094 and RS 21361 as antagonists of alpha-1 and alpha-2 adrenoceptors.

Authors:  P B Timmermans; J Q Qian; R R Ruffolo; P A van Zwieten
Journal:  J Pharmacol Exp Ther       Date:  1984-03       Impact factor: 4.030

6.  Estimation of partial agonist affinity by interaction with a full agonist: a direct operational model-fitting approach.

Authors:  P Leff; I G Dougall; D Harper
Journal:  Br J Pharmacol       Date:  1993-09       Impact factor: 8.739

7.  Indoline analogues of idazoxan: potent alpha 2-antagonists and alpha 1-agonists.

Authors:  G P Fagan; C B Chapleo; A C Lane; M Myers; A G Roach; C F Smith; M R Stillings; A P Welbourn
Journal:  J Med Chem       Date:  1988-05       Impact factor: 7.446

8.  Analysis of the activity of alpha 1-adrenoceptor antagonists in rat aorta.

Authors:  P H Van der Graaf; N P Shankley; J W Black
Journal:  Br J Pharmacol       Date:  1996-05       Impact factor: 8.739

9.  Pharmacological properties of the enantiomers of idazoxan: possible separation between their alpha-adrenoceptor blocking effects.

Authors:  H Dabire; J P Dausse; P Mouille; B Fournier; A Cardot; P Meyer; H Schmitt
Journal:  Clin Exp Hypertens A       Date:  1986
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.